PICU, ANDREEA LOREDANA
PICU, ANDREEA LOREDANA
Dip. MEDICINA INTERNA (attivo dal 01/01/1900 al 30/04/2013)
BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE
2009-01-01 A. Picu; E. Marinazzo; F. Prodam; F. Broglio; S. Belcastro; G. Amaretti; R. Giordano; E. Ghigo; E. Arvat
COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS
2006-01-01 M. Baldi; R. Giordano; A. Picu; M. Balbo; L. Bonelli; R. Berardelli; E. Ghigo; E Arvat
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM
2006-01-01 A. Picu; R. Giordano ; L. Bonelli; M. Balbo; M. Pellegrino; R. Berardelli; G. Corneli; V. Gasco; A. Gariano; E. Arvat
CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS
2006-01-01 M. Balbo; R. Giordano ; L. Bonelli; R. Berardelli; A. Picu; A. Benso; M. Barberis; E. Arvat
EFFECT OF FREE FATTY ACIDS ON ACTH AND CORTISOL SECRETION IN ANOREXIA NERVOSA
2004-01-01 A. Picu; L. Gianotti; R. Giordano; G. Abbate Daga; V. Mondelli; F. Lanfranco; G. Malfi; S. Fassino; E. Ghigo; E. Arvat
EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS
2009-01-01 R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat
EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE
2006-01-01 A. Picu; R. Giordano; L. Bonelli; R. Berardelli; S. Grottoli; F. Broglio; E. Ghigo; E Arvat
EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY
2008-01-01 A. Picu; R. Giordano; L. Bonelli; E. Marinazzo; R. Berardelli; M. Balbo; E. Ghigo; E. Arvat
EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA
2007-01-01 R. Berardelli; L. Gianotti; L. Bonelli; A. Picu; M. Balbo; R. Giordano; E. Ghigo; E. Arvat
EVALUATION OF BASAL AND STIMULATED ACTIVITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM
2003-01-01 M. Pellegrino; R. Giordano; M. Baldi; A. Picu; M. Balbo; E. Oleandri; C. Pellissetto; P. Limone; E. Ghigo; E. Arvat
EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM
2004-01-01 M. Pellegrino; R. Giordano; M. Baldi; A. Picu; M. Balbo; L. Bonelli; C. Pellissetto; P. Limone; E. Ghigo; E. Arvat
GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY
2011-01-01 R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat
HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION
2005-01-01 R. Giordano; A. Picu; U. Pagotto; R. De Iasio; L. Bonelli; F. Prodam; F. Broglio; R. Pasquali; M. Maccario; E. Ghigo; E. Arvat
HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS SENSITIVITY TO THE NEGATIVE FEED-BACK ACTION OF CORTISOL IN HUMANS
2003-01-01 R. Giordano; M. Baldi; M. Pellegrino; F. Lanfranco; M. Balbo; A. Picu; A. Barberis; E. Ghigo; E. Arvat
HYPOTHALAMO-PITUITARY-ADRENAL HYPERACTIVITY IN HUMAN AGING IS FURTHER ENHANCED BY MINERALCORTICOID ANTAGONISTS
2005-01-01 M. Pellegrino; R. Giordano; M. Baldi; M. Bo; M. Vezzari; A. Picu; M. Balbo; L. Bonelli; E. Ghigo; E. Arvat
LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS
2009-01-01 E. Marinazzo; R. Berardelli; A. Picu; G. Peraga; E. Ghigo; E. Arvat; R. Giordano
METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION
2010-01-01 A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat
Muscle fiber conduction slowing is a sensitive marker of steroid myopathy in Cushing’s disease
2011-01-01 Motta G; Lanfranco F; Botter A; Baldi M; Giordano R; Picu A; Ghigo E; Arvat E; Minetto MA
NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA
2005-01-01 M. Baldi; A. Picu; V. Mondelli; G. Abbate Daga; R. Giordano; F. Lanfranco; R. Berardelli; M. Balbo; S. Fassino; E. Arvat; L. Gianotti
NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS
2008-01-01 R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; L. Bonelli; M. Balbo; R. Giordano; M. Bo; E. Ghigo; E. Arvat
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BASAL AND STIMULATED GH SECRETION IN CUSHING’S SYNDROME: EFFECTS OF GHRELIN AND GHRH+ARGININE | 2009 | A. Picu; E. Marinazzo; F. Prodam; F. Broglio; S. Belcastro; G. Amaretti; R. Giordano; E. Ghigo; E. Arvat | |
| COMPARISON BETWEEN CORTISOL AND DEXAMETHASONE NEGATIVE FEEDBACK ACTION IN HUMANS | 2006 | M. Baldi; R. Giordano; A. Picu; M. Balbo; L. Bonelli; R. Berardelli; E. Ghigo; E Arvat | |
| COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM | 2006 | A. Picu; R. Giordano ; L. Bonelli; M. Balbo; M. Pellegrino; R. Berardelli; G. Corneli; V. Gasco; A. Gariano; E. Arvat | |
| CONVENTIONAL GLUCOCORTICOID REPLACEMENT THERAPY IN PATIENTS WITH ADDISON’S DISEASE: EFFECT ON METABOLIC AND BONE PARAMETERS | 2006 | M. Balbo; R. Giordano ; L. Bonelli; R. Berardelli; A. Picu; A. Benso; M. Barberis; E. Arvat | |
| EFFECT OF FREE FATTY ACIDS ON ACTH AND CORTISOL SECRETION IN ANOREXIA NERVOSA | 2004 | A. Picu; L. Gianotti; R. Giordano; G. Abbate Daga; V. Mondelli; F. Lanfranco; G. Malfi; S. Fassino; E. Ghigo; E. Arvat | |
| EFFECT OF PROLONGED TREATMENT WITH POTASSIUM CANRENOATE, A MR ANTAGONIST, ON BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) AXIS IN HUMANS | 2009 | R. Berardelli; E. Marinazzo; E. Prats; A. Picu; R. Giordano; I. Karamouzis; E. Ghigo; E Arvat | |
| EFFECTS OF CORTISTATIN-17 AND SOMATOSTATIN-14 ON ACTH AND CORTISOL HYPERSECRETION IN PATIENTS WITH CUSHING’S DISEASE | 2006 | A. Picu; R. Giordano; L. Bonelli; R. Berardelli; S. Grottoli; F. Broglio; E. Ghigo; E Arvat | |
| EFFECTS OF GHRELIN ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY | 2008 | A. Picu; R. Giordano; L. Bonelli; E. Marinazzo; R. Berardelli; M. Balbo; E. Ghigo; E. Arvat | |
| EFFECTS OF GNRH-RECEPTOR BLOCKADE ON GONADAL AXIS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA | 2007 | R. Berardelli; L. Gianotti; L. Bonelli; A. Picu; M. Balbo; R. Giordano; E. Ghigo; E. Arvat | |
| EVALUATION OF BASAL AND STIMULATED ACTIVITY OF THE HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM | 2003 | M. Pellegrino; R. Giordano; M. Baldi; A. Picu; M. Balbo; E. Oleandri; C. Pellissetto; P. Limone; E. Ghigo; E. Arvat | |
| EVALUATION OF BASAL AND STIMULATED HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) ACTIVITY IN PRIMARY HYPERALDOSTERONISM | 2004 | M. Pellegrino; R. Giordano; M. Baldi; A. Picu; M. Balbo; L. Bonelli; C. Pellissetto; P. Limone; E. Ghigo; E. Arvat | |
| GLUCOCORTICOID RECEPTOR POLYMORPHISMS AND METABOLIC-CARDIOVASCULAR PROFILE IN PATIENTS WITH ADDISON’S DISEASE UNDER REPLACEMENT THERAPY | 2011 | R. Giordano; S. Marzotti; R. Berardelli; I. Karamouzis; E. Marinazzo; A. Picu; D. Forno; D. Zinnà; D. Giachino; A. Falorni; E. Ghigo; E. Arvat | |
| HYPERCORTISOLISM DUE TO CUSHING’S DISEASE IS ASSOCIATED TO DERANGED GHRELIN SECRETION AND ACTION | 2005 | R. Giordano; A. Picu; U. Pagotto; R. De Iasio; L. Bonelli; F. Prodam; F. Broglio; R. Pasquali; M. Maccario; E. Ghigo; E. Arvat | |
| HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS SENSITIVITY TO THE NEGATIVE FEED-BACK ACTION OF CORTISOL IN HUMANS | 2003 | R. Giordano; M. Baldi; M. Pellegrino; F. Lanfranco; M. Balbo; A. Picu; A. Barberis; E. Ghigo; E. Arvat | |
| HYPOTHALAMO-PITUITARY-ADRENAL HYPERACTIVITY IN HUMAN AGING IS FURTHER ENHANCED BY MINERALCORTICOID ANTAGONISTS | 2005 | M. Pellegrino; R. Giordano; M. Baldi; M. Bo; M. Vezzari; A. Picu; M. Balbo; L. Bonelli; E. Ghigo; E. Arvat | |
| LONG-TERM MORPHOLOGICAL AND HORMONAL FOLLOW-UP IN A SERIES OF 124 ADRENAL INCIDENTALOMAS | 2009 | E. Marinazzo; R. Berardelli; A. Picu; G. Peraga; E. Ghigo; E. Arvat; R. Giordano | |
| METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CUSHING’S SYNDROME OF DIFFERENT ETIOLOGY BEFORE AND 1 YEAR AFTER DISEASE REMISSION | 2010 | A. Picu; E. Marinazzo; M. Balbo; R. Berardelli; I. Karamouzis; E. Ghigo; R. Giordano; E. Arvat | |
| Muscle fiber conduction slowing is a sensitive marker of steroid myopathy in Cushing’s disease | 2011 | Motta G; Lanfranco F; Botter A; Baldi M; Giordano R; Picu A; Ghigo E; Arvat E; Minetto MA | |
| NEUROENDOCRINE EFFECT OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), IN ANOREXIA NERVOSA | 2005 | M. Baldi; A. Picu; V. Mondelli; G. Abbate Daga; R. Giordano; F. Lanfranco; R. Berardelli; M. Balbo; S. Fassino; E. Arvat; L. Gianotti | |
| NEUROENDOCRINE EFFECTS OF CITALOPRAM, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR (SSRI), DURING LIFESPAN IN HUMANS | 2008 | R. Berardelli; E. Margarito; F. Ghiggia; A. Picu; L. Bonelli; M. Balbo; R. Giordano; M. Bo; E. Ghigo; E. Arvat |